Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 11.22 is 29% above its 5-year average of 8.73, around the middle of its 5-year range (0.79–24.75).
As of the fiscal period ended Tuesday, June 30, 2026. 8.06% below its 12-month average of 12.20.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 11.22.
QUICK RATIO (ACID-TEST)
11.22
QUICK RATIO (ACID-TEST) AVG TTM
12.20
QUICK RATIO (ACID-TEST) AVG 3Y
13.07
QUICK RATIO (ACID-TEST) AVG 5Y
8.73
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-8.06%
CURRENT VS 3Y AVG
-14.12%
CURRENT VS 5Y AVG
+28.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 849 covered companies
CURRENT VS SECTOR MEDIAN
+234.93%
vs the sector median at left
Satellos Bioscience Inc.
Market Cap
$10.37M
Quick Ratio (Acid-Test)
11.22
TTM Avg
12.20
3Y Avg
13.07
5Y Avg
8.73
Market Cap
$10.41M
Quick Ratio (Acid-Test)
2.64
TTM Avg
6.08
3Y Avg
6.44
5Y Avg
4.53
Market Cap
$10.30M
Quick Ratio (Acid-Test)
0.83
TTM Avg
3.08
3Y Avg
4.37
5Y Avg
4.67
Market Cap
$10.25M
Quick Ratio (Acid-Test)
0.86
TTM Avg
14.33
3Y Avg
8.45
5Y Avg
7.70
Market Cap
$10.60M
Quick Ratio (Acid-Test)
1.87
TTM Avg
6.83
3Y Avg
7.99
5Y Avg
8.70
Market Cap
$10.58M
Quick Ratio (Acid-Test)
36.37
TTM Avg
19.59
3Y Avg
9.84
5Y Avg
7.09
Market Cap
$10.65M
Quick Ratio (Acid-Test)
3.69
TTM Avg
5.96
3Y Avg
7.84
5Y Avg
10.45
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Satellos Bioscience Inc. (MSLE) | $10.37M | 11.22 | 12.20 | 13.07 | 8.73 |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.41M | 2.64 | 6.08 | 6.44 | 4.53 |
| Senti Biosciences, Inc. (SNTI)vs › | $10.30M | 0.83 | 3.08 | 4.37 | 4.67 |
| Valion Bio, Inc. (VBIO)vs › | $10.25M | 0.86 | 14.33 | 8.45 | 7.70 |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.60M | 1.87 | 6.83 | 7.99 | 8.70 |
| Lifeward Ltd. (LFWD)vs › | $10.52M | 1.77 | 1.14 | 4.92 | 7.75 |
| Polyrizon Ltd. (PLRZ)vs › | $10.58M | 36.37 | 19.59 | 9.84 | 7.09 |
| Pluri Inc. (PLUR)vs › | $10.59M | 0.27 | 0.48 | 3.83 | 4.93 |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.65M | 3.69 | 5.96 | 7.84 | 10.45 |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.08M | 1.57 | 1.67 | 1.44 | 1.16 |
Quick Ratio
11.22
Excludes inventory
Current Ratio
11.22
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 11.22 |
| 2026-03-31 | 16.48 |
| 2025-12-31 | 7.77 |
| 2025-09-30 | 10.70 |
| 2025-06-30 | 14.84 |
| 2025-03-31 | 16.44 |
| 2024-12-31 | 14.16 |
| 2024-09-30 | 6.68 |
| 2024-06-30 | 7.25 |
| 2024-03-31 | 9.13 |
| 2023-12-31 | 11.13 |
| 2023-09-30 | 19.29 |
| 2023-06-30 | 24.75 |
| 2023-03-31 | 1.00 |
| 2022-12-31 | 0.79 |
| 2022-09-30 | 1.69 |
| 2022-06-30 | 1.04 |
| 2022-03-31 | 2.14 |
| 2021-12-31 | 2.59 |
| 2021-09-30 | 3.29 |
| 2021-06-30 | 0.98 |
| 2021-03-31 | 1.14 |
| 2020-12-31 | 5.13 |
| 2020-09-30 | 0.58 |
| 2020-06-30 | 0.75 |
| 2020-03-31 | 1.03 |
| 2019-12-31 | 1.81 |
| 2019-09-30 | 4.37 |
| 2019-06-30 | 0.61 |
| 2019-03-31 | 1.17 |
| 2018-12-31 | 0.22 |
| 2018-09-30 | 0.39 |
| 2018-06-30 | 1.06 |
| 2018-03-31 | 4.21 |
| 2017-12-31 | 4.77 |
